Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Altimmune Inc (NASDAQ:ALT)

1.61
Delayed Data
As of Dec 15
 -0.01 / -0.62%
Today’s Change
1.51
Today|||52-Week Range
14.70
-58.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues17.9M10.2M10.6M5.2M
 
 
 
 
 
Depreciation And Amortization182.5K150.0K141.6K143.4K
 
 
 
 
 
 
Operating ExpensesGross Income--10.0M----
 
 
General Expenses24.8M20.2M11.4M16.4M
 
 
 
 
 
Research And Development14.8M9.3M5.1M4.8M
 
 
 
 
 
Total Operating Expenses25.0M20.4M11.5M16.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.0M-10.2M-856.6K-11.3M
 
 
 
 
 
Extraordinary Credit0.00508.8K299.5K217.1M
 
 
 
 
Extraordinary Charge-4.2M---2.5M-957.1K
 
 
 
 
Interest Expense On Debt369.3K211.1K54.6K--
 
 
 
 
Other Expenses-6.1K-762.00-221.1K7.8K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.7M-9.9M-3.4M205.0M
 
 
 
 
 
Income Taxes-61.7K-61.7K-61.7K-11.2M
 
 
 
 
 
Net Income-11.7M-10.0M-3.4M193.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.1M5.8M6.4M6.5M
 
 
 
 
 
Shares To Calculate EPS Diluted5.1M5.8M6.4M6.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.30-$1.70-$0.50$29.50
 
 
 
 
 
EPS Diluted-$2.30-$1.70-$0.50$29.50